NCT05964504Recruiting
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Improving Survival for Those With Metastatic Lobular Breast Cancer Through Development of the Multi-center PLUMB Registry-a Prospective Study of LobUlar Metastatic Breast Cancer
Source: ClinicalTrials.gov · Last updated 2 Sept 2026
Brief summary (registry, in English)
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 19 Jul 2023
- Start date
- 20 Dec 2023
- Primary completion date
- 28 Feb 2036
- Lead sponsor
- University of California, San Francisco
- Diseases
- Metastatic breast cancer
- NCT number
- NCT05964504
What you commit to
- Study type: Observational
- Planned participants: 150
- From 20 Dec 2023 to the primary completion date, 28 Feb 2036
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Other active cancer (prior treated cancer with no current evidence of disease is allowed).
Other illness
- Stage I-III breast cancer.
Other
- Lack of lobular histology on tumor biopsy.
Who the study is looking for
- Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
- Age \>=18 years
- Any receptor subtype.
- Ability to understand a written informed consent document, and the willingness to sign it.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
| Abramson Cancer Center Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
| University of California San Diego Coordinator of this site? Confirm its status | San Diego | United States | Recruiting |
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.